Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymers to treat brain tumours.

H Brem1

  • 1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Biomaterials
|November 1, 1990
PubMed
Summary

Biodegradable polymers loaded with carmustine offer a promising new treatment for brain tumors, showing improved effectiveness and safety in clinical trials. This drug delivery method is being further investigated for brain disease applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical and anaplastic meningioma: outcomes in a population based study.

Journal of neuro-oncology·2017
Same author

Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.

Oncogene·2016
Same author

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Nature·2006
Same author

Late-onset facial nerve degeneration after vestibular schwannoma surgery: incidence, putative mechanisms, and prevention.

Neurosurgical focus·2006
Same author

Hemorrhagic vestibular schwannoma: an unusual clinical entity. Case report.

Neurosurgical focus·2006
Same author

Comparative analysis of paracrine immunotherapy in experimental brain tumors.

Neurosurgical focus·2006

Area of Science:

  • Biomaterials Science
  • Neuro-oncology
  • Drug Delivery Systems

Background:

  • Conventional brain tumor treatments face significant challenges.
  • Biodegradable polymers offer a novel approach for localized drug delivery.
  • Poly-[bis(p-carboxyphenoxy)propane sebacic acid] is a biocompatible polymer with sustained drug release properties.

Purpose of the Study:

  • To evaluate the efficacy and safety of carmustine delivered via a biodegradable polymer for brain tumor treatment.
  • To explore the potential of this polymer-based drug delivery system in neuro-oncology.
  • To discuss broader applications of the polymer in treating brain diseases.

Main Methods:

  • Impregnation of carmustine (a nitrosourea) into a biodegradable polymer, poly-[bis(p-carboxyphenoxy)propane sebacic acid].
  • Assessment of polymer biocompatibility and drug release in animal models.
  • Phase I clinical study to evaluate safety in human patients.
  • Ongoing Phase III placebo-controlled clinical trial.

Main Results:

  • The polymer demonstrated biocompatibility in animal brains.
  • Predictable and sustained drug release was observed.
  • Carmustine delivered via polymer showed enhanced effectiveness compared to standard methods.
  • Phase I trials confirmed the safety of this approach for brain tumor treatment.

Conclusions:

  • Biodegradable polymer-based carmustine delivery is a safe and effective strategy for brain tumors.
  • This method shows superior efficacy over conventional treatments.
  • Further research is warranted for its application in other brain diseases.

Related Experiment Videos